Matinas BioPharma Holdings, Inc. (MTNB): Total Assets
$7.21M
As of 2025-12-31
$3.41M
As of 2026-06-30
-45.6%
3-year compound annual growth
-36.7%
5-year compound annual growth
-1.5%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.21M | -43.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $12.64M | -49.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $25.10M | -44.0% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $44.82M | -26.9% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $61.33M | -13.6% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $70.97M | +76.4% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $40.24M | +101.8% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $19.94M | +38.3% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $14.42M | +46.9% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $9.82M | +16.8% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $8.41M | +150.1% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $3.36M | -70.3% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $11.33M | n/a | 2015-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $7.21M | -43.0% |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $7.34M | +454.5% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.96M | -12.2% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $7.58M | -43.5% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $6.84M | +23.5% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $7.60M | -1.4% |
Compare MTNB, TELO, CPMD, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗